SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-22-000978
Filing Date
2022-05-12
Accepted
2022-05-12 17:25:56
Documents
53
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bdpt_10q.htm   iXBRL 10-Q 527924
2 CERTIFICATE bdpt_ex311.htm EX-31.1 10493
3 CERTIFICATE bdpt_ex312.htm EX-31.2 11054
4 CERTIFICATE bdpt_ex321.htm EX-32.1 3422
5 CERTIFICATE bdpt_ex322.htm EX-32.2 4008
11 bdpt_10qimg1.jpg GRAPHIC 3875
  Complete submission text file 0001640334-22-000978.txt   3029614

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bdpt-20220331.xsd EX-101.SCH 35270
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdpt-20220331_lab.xml EX-101.LAB 210534
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdpt-20220331_cal.xml EX-101.CAL 36147
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdpt-20220331_pre.xml EX-101.PRE 177088
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdpt-20220331_def.xml EX-101.DEF 108027
47 EXTRACTED XBRL INSTANCE DOCUMENT bdpt_10q_htm.xml XML 395831
Mailing Address 1015 S CIMARRON RD LAS VEGAS NV 89145
Business Address 1015 S CIMARRON RD LAS VEGAS NV 89145 (702) 560-1632
BIOADAPTIVES, INC. (Filer) CIK: 0001575142 (see all company filings)

IRS No.: 462592228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54949 | Film No.: 22919148
SIC: 2834 Pharmaceutical Preparations